RK RKLB Rocket Lab USA Loading... : Bullish and Bearish Analyst Opinions

Named in Space/Aviation sector accumulation list during a high-beta sell-off dip.

Author notes that ASTS volatility was short-lived as the market realized the offering was less bearish than initially thought, and sees other space names ending green as a sign of nearing a bottom.

The author lists thematic ETFs and beaten-down AI, neocloud, space, and defense stocks as a watchlist for which sectors might rally first, not as current positions or trade calls.

The author presents a list of beaten-down stocks across AI semis, neocloud, space, and defense sectors as being "on sale," but does not state a personal position or explicit forward call, so each ticker is indexed as watch.

RKLB down 55% from ATH ($150→$67) despite continued space/launch contract wins. The sell-off is part of the brutal high-beta unwind, but the company's backlog and launch cadence are accelerating. At 55% off highs, the stock is pricing in major failure that isn't materializing; valuation becomes compelling relative to growth trajectory. Space sector volatility; potential dilution; macro headwinds for speculative growth.

The author describes a broad sell-off in retail-favored growth stocks but frames it as a natural consequence of prior gains, not a trade call.

Author lists growth stocks down from highs as a factual observation of portfolio destruction, with a vague recovery timeline but no explicit position or forward call.

The author agrees that space names would have been hit hard regardless, noting RKLB was especially close to ASTS's heels after the open, but offers no forward position.

Named as a cheaper individual alternative to SPCX for launch exposure, in a comparative thesis against the basket.

Buy RKLB as the top-weighted Space Economy holding; author deploys fresh capital into space economy theme citing AI buildout tailwinds and sentiment-driven dip in high-beta names down 30-50%.

The author notes that RKLB and ASTS are both down over 50% from all-time highs, but does not state a position or forward call.

Author lists four tickers in reply to a generic bullish post, no directional commitment or catalyst.

Author says he bought RKLB more than a year ago at $27 and defends the long-term holding despite the short-term selloff.

The tweet notes Rocket Lab is down 57% from its high and compares it negatively to crypto, but expresses no position or forward-looking trade idea.

The author dismisses the quoted list of beaten-down momentum names as never attractive on valuation, but does not express a personal long or short position, only a skeptical watchlist view.

The author warns that high retail leverage and short seller aggression in the space basket create risk, advising caution rather than taking a directional position.

The author warns that these space stocks have high retail leverage and are targeted by short sellers, advising caution rather than taking a directional position.

The author lists space stocks that have fallen sharply despite unchanged or improved fundamentals, framing the selloff as indiscriminate rather than making a forward trade call.

Author discloses RKLB as one of four current concentrated portfolio holdings; ongoing position with no new catalyst stated.

The author expresses confusion and frustration over RKLB's market cap drop linked to ASTS's offering, but does not state a personal position or forward-looking trade.

Piper Sandler initiates coverage with Neutral rating and $83 target, a substantive analyst action but no personal directional view from speaker.

Buy RKLB as the stock has halved from ATH despite improved business outlook from the IRDM acquisition and upcoming Neutron launch, creating a compelling entry.

Author sees potential for ONDS in 2027-2030 but calls it tough to call now, while noting other stocks like RKLB may get them there first.

Buy Rocket Lab at $60; author's stated add-zone target based on undervaluation assessment, with patient entry strategy contingent on bullish market conditions.

The author predicts a future share price crossover between Rocket Lab and Space X's tracker, but uses speculative language without stating a current position.

The author anticipates a market cap crossover between Rocket Lab and SPCX as a notable milestone, but does not state a personal position or forward call.

A +9 upvoted comment notes RKLB is “down 50% from one month ago” and explicitly states “accumulating at these levels”. Sharp drawdown in a high-growth space stock creates a potential mean-reversion or value play, especially if sentiment has become overly pessimistic. Accumulation rhetoric signals a bottom-fishing attempt. Long RKLB on the pullback for a speculative swing; community sees cheap entry after 50% drop. A sarcastic comment (“people unironically invest in space stocks”) warns of meme-like greed. No catalyst in sight; further downside possible.

The author simply spotted and shared a tweet about OUST and RKLB without expressing any personal position or forward-looking view.

The author simply flags OUST and RKLB as stocks to watch without stating any position or forward-looking directional view.

Author explicitly states they are building a large position in ONDS at current levels, expecting 5-10x upside by 2030, comparing it to their earlier successful RKLB investment.